FIELD: medicine.
SUBSTANCE: offered medicinal agents are applied to prevent post acute stroke infections. As such mezlocylline, moxifloxacine, cy-lastatine, imipenem and sulbactam, or gamma-interferon is offered. At that preventive therapy starts in 12-72 hours after stroke. Immunomodulating properties of propranolol are discovered for application to prevent infectious starting before 12 hours after stroke, specifically after stroke.
EFFECT: invention enables to prevent serious bacterial infectious and increase post-stroke survival rate.
8 cl, 4 ex, 10 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| USING LYSOZYME DIMER AS DRUG AND COMPOSITIONS CONTAINING THEREOF | 1993 |
|
RU2145875C1 |
| METHOD FOR STROKE TREATMENT | 2014 |
|
RU2571282C1 |
| METHOD OF PREDICTING INFECTIOUS COMPLICATIONS OF CRITICAL CONDITION | 2020 |
|
RU2743453C1 |
| METHOD FOR ACCOMPANYING TREATMENT OF LYMPHOBLAST LEUCOSIS | 2006 |
|
RU2320367C1 |
| METHOD FOR PROTECTION AGAINST CORONAVIRUS INFECTION | 2020 |
|
RU2747467C1 |
| METHOD FOR PREVENTING ENT- AND RESPIRATORY ORGAN DISEASES CAUSED BY VIRUSES AND NON-SPECIFIC BACTERIAL FLORA IN EARLY AGE CHILDREN BORN BY HIV-INFECTED MOTHERS | 2004 |
|
RU2289425C2 |
| METHOD OF ACUTE RESPIRATORY DISEASES PREVENTION DURING POSTVACCINAL PERIOD FOR CHILDREN SUFFERING FROM CHRONIC GLOMERULONEPHRITIS AND CHRONIC RENAL INSUFFICIENCY | 2005 |
|
RU2325182C2 |
| METHOD OF ADAPTIVE IMMUNOTHERAPY | 1994 |
|
RU2098125C1 |
| USE OF LEVOCETIRIZINE AND MONTELUKAST IN TREATMENT OF TRAUMATIC INJURY | 2014 |
|
RU2672871C2 |
| COMPOSITION WITH ANTI-INFECTIOUS ACTIVITY | 2012 |
|
RU2476205C1 |
